Literature DB >> 6997053

Cyclophosphamide cardiotoxicity.

G von Bernuth, D Adam, R Hofstetter, D Lang, W Mohr, E Kohne, D Niethammer.   

Abstract

A 12-year-old boy with aplastic anemia developed severe but reversible cardiac failure after treatment with 200 mg/kg cyclophosphamide (4 x 50 mg/kg on four consecutive days) given as preparation for bone marrow grafting. This and previously reported cases demonstrate the possibility of cardiotoxicity after high doses of the drug.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6997053     DOI： 10.1007/bf00442410

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  11 in total

1.  Marrow transplanation in man following cyclophosphamide.

Authors:  G W Santos; L L Sensenbrenner; P J Burke; M Colvin; A H Owens; W B Bias; R E Slavin
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

2.  Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.

Authors:  C D Buckner; R Briggs; R A Clift; A Fefer; D D Funk; H Glucksberg; P E Neiman; R Storb; E D Thomas
Journal:  Cancer Chemother Rep       Date:  1974 Sep-Oct

3.  Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.

Authors:  T X O'Connell; M C Berenbaum
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

4.  Cardiac pathologic findings in patients treated with bone marrow transplantation.

Authors:  L M Buja; V J Ferrans; R G Graw
Journal:  Hum Pathol       Date:  1976-01       Impact factor: 3.466

5.  Allogeneic marrow grafting for treatment of aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; F L Johnson; A Fefer; H Glucksberg; E R Giblett; K G Lerner; P Neiman
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

6.  Aplastic anemia treated by marrow transplantation.

Authors:  C D Buckner; R A Clift; A Fefer; D D Funk; H Glucksberg; R E Ramberg; R Storb; E D Thomas
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

Review 7.  The pathology of bone marrow transplantation.

Authors:  R E Slavin; J M Woodruff
Journal:  Pathol Annu       Date:  1974

8.  Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity.

Authors:  F Appelbaum; J A Strauchen; R G Graw; D D Savage; K M Kent; V J Ferrans; G P Herzig
Journal:  Lancet       Date:  1976-01-10       Impact factor: 79.321

9.  Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.

Authors:  R Storb; C D Buckner; L A Dillingham; E D Thomas
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

10.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113
View more
  4 in total

1.  Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin.

Authors:  B Isberg; C Paul; L Jönsson; U Svahn
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Minimising the long-term adverse effects of childhood leukaemia therapy.

Authors:  Claudia Langebrake; Dirk Reinhardt; Jörg Ritter
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

4.  Bone marrow transplantation may augment cardiac systolic function in patients with a reduced left ventricular ejection fraction.

Authors:  Mohammad A Piranfar; Mersedeh Karvandi; Shahrooz Yazdani; Mehdi Pishgahi; Mahshid Mehdizadeh; Abbas Hajfathali; Mehdi Tabarraee
Journal:  J Cardiovasc Dis Res       Date:  2012-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.